Autoimmune Hepatitis: Clinical Trials

5 trials for Autoimmune Hepatitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed, 1 recruiting, 1 terminated. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Unknown 2, Completed 1, Recruiting 1, Terminated 1
Phase 21Unknown 1

Follow Autoimmune Hepatitis: new trials by email Literature Review of Autoimmune Hepatitis trials Research Report on Autoimmune Hepatitis

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of SIPLIZUMAB in AILD and LT Patients
Siplizumab - Autoimmune Liver Disease, Liver Transplant Disorder
Phase 1RecruitingElizabeth C. Verna82024-09-112025-11-24
A Pharmacokinetic Study of JKB-122 Tablets Compared to Capsule
JKB-122 in capsule or tablet form - Autoimmune Hepatitis
Phase 1UnknownTaiwanJ Pharmaceuticals Co., Ltd82020-08-012020-07-15
Abatacept for Treatment of Recurrent or de Novo Autoimmune Hepatitis
Orencia® (Abatacept) - Autoimmune Hepatitis
Phase 1TerminatedStuart Knechtle, M.D.12020-03-092021-11-29
sPIF CLINICAL STUDY PROTOCOL IN AUTOIMMUNE HEPATITIS
sPIF, Placebo - Autoimmune Hepatitis
Phase 1CompletedChristopher O'Brien, MD362014-11-142019-11-20
Umbilical Cord Mesenchymal Stem Cells for Patients With Autoimmune Hepatitis
conventional plus UC-MSC treatment, Conventional plus placebo treatment - Autoimmune Hepatitis
Phase 1 / Phase 2UnknownBeijing 302 Hospital1002011-10-012013-05-31

Narrower conditions

Hepatitis, Autoimmune (5)  ·  Cholangitis, Sclerosing (1)  ·  End Stage Liver Disease (1)  ·  Hepatitis (1)  ·  Liver Cirrhosis (1)

Broader conditions

Autoimmune Diseases (5)  ·  Digestive System Diseases (5)  ·  Hepatitis, Chronic (5)  ·  Immune System Diseases (5)  ·  Liver Diseases (5)  ·  Hepatitis (4)  ·  Bile Duct Diseases (1)  ·  Biliary Tract Diseases (1)  ·  Cholangitis (1)  ·  Fibrosis (1)  ·  Hepatic Insufficiency (1)  ·  Liver Failure (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Abatacept (1)  ·  Capsules (1)  ·  Congresses as Topic (1)  ·  JKB-122 (1)  ·  Ringer's Lactate (1)  ·  preimplantation factor, synthetic (1)  ·  siplizumab (1)

Sponsors

Beijing 302 Hospital (1)  ·  Christopher O'Brien, MD (1)  ·  Elizabeth C. Verna (1)  ·  Stuart Knechtle, M.D. (1)  ·  TaiwanJ Pharmaceuticals Co., Ltd (1)

Countries

United States (3)  ·  China (1)

Top investigators

Christopher B. O'Brien, MD (1)  ·  Elizabeth Verna, MD (1)  ·  Fu-Sheng Wang, professor (1)  ·  Stuart Knechtle, MD (1)

Results publications

PMID 26257082, PMID 28704412